Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

Cancer drug developer Revolution (RVMD.US) surged after hours! Rumored to be in talks with Merck & Co., Inc. (MRK.US) for acquisition, with the transaction price potentially reaching $32 billion.

Northeast: Ningbo Joyson Electronic Corp. (00699) given a "buy" rating, major breakthrough in smart driving business.

Wu Yuefeng will strategically invest 500 million yuan in BLACK SESAME (02533) to empower the end-side AI and embodied intelligent ecological layout in the long term.

Cancer drug developer Revolution (RVMD.US) surged after hours! Rumored to be in talks with Merck & Co., Inc. (MRK.US) for acquisition, with the transaction price potentially reaching $32 billion.

Northeast: Ningbo Joyson Electronic Corp. (00699) given a "buy" rating, major breakthrough in smart driving business.

Wu Yuefeng will strategically invest 500 million yuan in BLACK SESAME (02533) to empower the end-side AI and embodied intelligent ecological layout in the long term.